(Q77114661)

English

Cost-utility analysis of melphalan plus prednisone with or without interferon-alpha 2b in newly diagnosed multiple myeloma. Results from a randomised controlled trial

scientific article published on 01 July 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169390%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Cost-utility analysis of melphalan plus prednisone with or without interferon-alpha 2b in newly diagnosed multiple myeloma. Results from a randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169390%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

randomized controlled trial

1 reference

based on heuristic

inferred from title

author name string

E Nord

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169390%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

F Wisløff

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169390%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

M Hjorth

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169390%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J Westin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169390%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 July 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169390%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169390%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169390%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169390%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

89-103

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169390%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

The validity of using health state indexes in measuring the consequences of traffic injury for public health.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health values of the seriously ill. SUPPORT investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Has the incidence of multiple myeloma in old age been underestimated? The myeloma project of health region I in Norway. I

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health status index models for use in resource allocation decisions. A critical review in the light of observed preferences for social choice

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The friction cost method for measuring indirect costs of disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha for induction and maintenance in multiple myeloma: Results of two multicenter randomized trials and summary of other studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standard treatment of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of trends in the incidence of multiple myeloma in Malmö, Sweden, and other countries, 1950-1979.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Social evaluation of health care versus personal evaluation of health states. Evidence on the validity of four health-state scaling instruments using Norwegian and Australian surveys

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The economics of hypertension and stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toward quality assurance in QALY calculations

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The trade-off between severity of illness and treatment effect in cost-value analysis of health care

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-utility in practice: a policy maker's guide to the state of the art.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utilities and quality-adjusted life years

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of cost-effectiveness analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/10169390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77114661&oldid=2222787565"